Status:
COMPLETED
Cell Salvage and Retrograde Autologous Priming
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Surgery
Hemodynamic Instability
Eligibility:
All Genders
18+ years
Brief Summary
In recent years Patient Blood Management (PBM) has developed into a multifactorial and interdisciplinary concept that focuses on individualized and optimized hemotherapy. Of course, this also applies ...
Detailed Description
200 patients (CABG or AVR) will be monitored using local standard of care in these patients without cell salvage and RAP (control group, CG), followed by 200 patients with cell salvage and RAP (study ...
Eligibility Criteria
Inclusion
- scheduled for cardiac surgery
- informed written consent
Exclusion
- rejection by the patient
- switching to another procedure
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04792814
Start Date
June 1 2018
End Date
October 31 2019
Last Update
March 11 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Schleswig-Holstein Campus Kiel - Klinik für Anästhesiologie und Operative Intensivmedizin
Kiel, Deutschland (deu), Germany, 24105
2
GERMANY - Universitätsklinikum Schleswig-Holstein
Kiel, Schleswig-Holstein, Germany, 24109